Validation Data Gallery
Filter:
Tested Applications
| Positive WB detected in | A431 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Published Applications
| KD/KO | See 2 publications below |
| WB | See 3 publications below |
| IHC | See 1 publications below |
| IF | See 2 publications below |
Product Information
12839-1-AP targets MAPK6 in WB, IF, IHC, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human, rat |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen | MAPK6 fusion protein Ag3577 相同性解析による交差性が予測される生物種 |
| Full Name | mitogen-activated protein kinase 6 |
| Calculated molecular weight | 83 kDa |
| Observed molecular weight | 100-105 kDa |
| GenBank accession number | BC035492 |
| Gene Symbol | MAPK6 |
| Gene ID (NCBI) | 5597 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q16659 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol , pH 7.3 |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
Publications
| Species | Application | Title |
|---|---|---|
Sci Rep MicroRNA-26a targets MAPK6 to inhibit smooth muscle cell proliferation and vein graft neointimal hyperplasia.
| ||
J Exp Clin Cancer Res LncMAPK6 drives MAPK6 expression and liver TIC self-renewal.
| ||
Exp Ther Med miR-98 inhibits cell proliferation and induces cell apoptosis by targeting MAPK6 in HUVECs. |